Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"EC 2.7.10.1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Perrone%2C+Francesco%22&type=Person&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22
/vufind/Search/Results?lookfor=%22Perrone%2C+Francesco%22&type=Person&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22
Search /vufind/Search2/Results?lookfor=%22Perrone%2C+Francesco%22&type=Person&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22
PubPharm (23)
1
Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial
enthalten in:
Journal of experimental & clinical cancer research : CR
| 2023
von
Forlani, L.
|
De Cecco, L.
|
Simeon, V.
| +21
Wird geladen...
2
Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC : The BEVERLY Multicenter Randomized Phase 3 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2022
von
Piccirillo, M.
|
Bonanno, L.
|
Garassino, M.
| +30
Wird geladen...
3
cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors : Time for clinical implementation?
enthalten in:
EBioMedicine
| 2020
von
Normanno, N.
|
De Luca, A.
|
Perrone, F.
CommentOn: EBioMedicine. 2020 Jul;57:102861. - PMID 32629391
Wird geladen...
4
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3) : a randomised, phase 3 trial
enthalten in:
The Lancet. Oncology
| 2018
von
De Placido, S.
|
Gallo, C.
|
De Laurentiis, M.
| +128
CommentIn: Lancet Oncol. 2018 Apr;19(4):431-432. - PMID 29482984
Wird geladen...
5
BEVERLY : Rationale and Design of a Randomized Open-Label Phase III Trial Comparing Bevacizumab Plus Erlotinib Versus Erlotinib Alone as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous Non-Small-Cell Lung Cancer
enthalten in:
Clinical lung cancer
| 2016
von
Gridelli, C.
|
Rossi, A.
|
Ciardiello, F.
| +10
Wird geladen...
6
Afatinib : An overview of its clinical development in non-small-cell lung cancer and other tumors
enthalten in:
Critical reviews in oncology/hematology
| 2016
von
Giordano, P.
|
Manzo, A.
|
Montanino, A.
| +10
Wird geladen...
7
Treatment of Elderly Patients With Non-Small-Cell Lung Cancer : Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology
enthalten in:
Clinical lung cancer
| 2015
von
Gridelli, C.
|
Balducci, L.
|
Ciardiello, F.
| +7
CommentIn: Clin Lung Cancer. 2016 Mar;17(2):e25-7. - PMID 26700909
Wird geladen...
8
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26) : a double-blind, randomised, phase 3 trial
enthalten in:
The Lancet. Oncology
| 2014
von
Ellis, P.
|
Shepherd, F.
|
Millward, M.
| +24
CommentIn: Lancet Oncol. 2014 Nov;15(12):1289-90. - PMID 25439684
Wird geladen...
9
Combining anti-Epidermal Growth Factor Receptor (EGFR) and anti-angiogenic strategies in advanced NSCLC : we should have known better…
enthalten in:
Current pharmaceutical design
| 2014
von
Di Maio, M.
|
Morabito, A.
|
Piccirillo, M.
| +7
Wird geladen...
10
Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations : current evidence and future perspectives
enthalten in:
Expert review of anticancer therapy
| 2013
von
Costanzo, R.
|
Montanino, A.
|
Di Maio, M.
| +9
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: EC 2.7.10.1
Medienart
23
Aufsätze
17
E-Artikel
17
E-Ressourcen
6
Gedruckte Aufsätze
Zeitschriftentitel
3
The Lancet. Oncology
3
The oncologist
2
Clinical lung cancer
2
Endocrine-related cancer
2
Expert review of anticancer therapy
2
Journal of clinical oncology : official journal...
1
Critical reviews in oncology/hematology
1
Current opinion in oncology
1
Current pharmaceutical design
1
EBioMedicine
1
Journal of biomedicine & biotechnology
1
Journal of cellular physiology
1
Journal of experimental & clinical cancer resea...
1
Journal of thoracic oncology : official publica...
1
Lung cancer (Amsterdam, Netherlands)
Alle anzeigen ...
weniger ...
Thema
EC 2.7.10.1
21
Journal Article
18
ErbB Receptors
14
Review
11
Protein Kinase Inhibitors
11
Research Support, Non-U.S. Gov't
8
Antineoplastic Agents
7
Quinazolines
5
Clinical Trial, Phase III
5
DA87705X9K
5
EGFR protein, human
5
Erlotinib Hydrochloride
5
Randomized Controlled Trial
4
Multicenter Study
4
Receptor, ErbB-2
3
2S9ZZM9Q9V
3
Angiogenesis Inhibitors
3
Antibodies, Monoclonal
3
Bevacizumab
3
Comment
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3
2020-
12
2010-2019
8
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
23
Englisch
Haven't found what you're looking for?
Wird geladen...